UPT Perpustakaan Universitas Andalas
Repositori PerpustakaanUniversitas Andalas
 

PENINGKATAN LAJU DISOLUSI MELOKSIKAM MENGGUNAKAN TEKNIK CO-GRINDING (PENGGILINGAN BERSAMA) DENGAN POLIMER POLIVINILPIROLIDON (PVP K-30)

dc.contributor.authorGusti, Feni Rahayu
dc.date.accessioned2026-09-24T22:21:03Z
dc.date.issued2012-08
dc.descriptionDr.Erizal,S.Si,M.Si, Apt., Dr.Febrfyenti,S.Si, M.Si, Apt
dc.description.abstractPenelitian mengenai efek padatan co-grinding telah dilakukan menggunakan meloksikam sebagai model obat yang sukar larut, dengan polimer hidrofilik polivinilpirolidon (PVP K-30). Proses co-grinding dilakukan menggunakan alat ball mill dengan tujuan meningkatkan laju disolusi meloksikam. Meloksikam merupakan obat antiinflamasi nonsteroid (AINS) yang digunakan dalam terapi rheumatoid arthritis, osteoartritis, dan nyeri sendi. Obat ini memiliki permeabilitas tinggi pada saluran cerna, tetapi kelarutannya dalam air rendah. Perbandingan meloksikam dengan PVP K-30 yang digunakan dalam penelitian ini adalah 1:1, 1:3, dan 1:5. Metode co-grinding dengan ball mill dapat memengaruhi karakterisasi padatan kristal obat, sehingga berpotensi meningkatkan laju disolusi. Untuk mengamati perubahan karakterisasi padatan dan kemungkinan interaksi antara obat dan polimer, dilakukan beberapa analisis terhadap campuran fisik dan campuran co-grinding, yaitu: Analisis difraksi sinar-X (XRD), Analisis Differential Thermal Analysis (DTA), Analisis Scanning Electron Microscopy (SEM), Analisis spektroskopi FT-IR, Analisis distribusi ukuran partikel, Uji disolusi menggunakan metode dayung (apparatus II) Hasil analisis difraksi sinar-X pada campuran co-grinding meloksikam–PVP K-30 menunjukkan terjadinya penurunan derajat kristalinitas obat. Data DTA menunjukkan penurunan suhu dan intensitas puncak endotermik secara signifikan pada campuran co-grinding. Hasil analisis XRD dan DTA mengindikasikan bahwa proses co-grinding menyebabkan transformasi fase dari bentuk kristal menjadi bentuk amorf. Analisis FT-IR menunjukkan tidak adanya interaksi kimia antara meloksikam dan PVP K-30 dalam campuran co-grinding. Hasil uji disolusi menunjukkan bahwa campuran co-grinding dengan perbandingan 1:3 memberikan peningkatan laju disolusi paling tinggi dibandingkan perbandingan lainnya.
dc.identifier.urihttps://ailib.my.id/handle/123456789/62886
dc.language.isoid
dc.publisherUniversitas Andalas
dc.subject.classificationRS Pharmacy and materia medica
dc.titlePENINGKATAN LAJU DISOLUSI MELOKSIKAM MENGGUNAKAN TEKNIK CO-GRINDING (PENGGILINGAN BERSAMA) DENGAN POLIMER POLIVINILPIROLIDON (PVP K-30)
dc.typeThesis
dcterms.dateSubmitted2026-02-23
dcterms.referencesAbdou, H. M. (1989). Dissolution, bioavailability and bioequivalence. Pennsylvania: Mack Publishing Company. Aguiar, A. J., Krc, J., Kinkel, A. W., & Samyn, J. C. (1967). Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate. Journal of Pharmaceutical Sciences, 56, 847–853. American Society of Health-System Pharmacists. (2005). American Hospital Formulary Drug Information. Bethesda: ASHP. Anonim. (1995). Farmakope Indonesia (Edisi III). Jakarta: Departemen Kesehatan Republik Indonesia. Banakar, U. V. (1991). Pharmaceutical dissolution testing. New York: Marcel Dekker. Bazegar-Jalali, M., Valizadeh, H., & Adibkia, K. (2007). Enhancing dissolution rate of carbamazepine via co-grinding with crospovidone and hydroxypropyl methylcellulose. Iranian Journal of Pharmaceutical Research, 6(3), 159–165. British National Formulary. (2008). British National Formulary (Edisi ke-57). London: Royal Pharmaceutical Society of Great Britain. Brittain, H. G. (2002). Effects of mechanical processing on phase composition. Journal of Pharmaceutical Sciences, 91(7), 1573–1580. Chieng, N., Zujovic, Z., Bowmaker, G., Rades, T., & Saville, D. (2006). Effect of milling conditions on solid-state conversion of ranitidine hydrochloride form I. International Journal of Pharmaceutics, 327, 36–44. Chiou, W. L., & Riegelman, S. (1971). Pharmaceutical applications of solid dispersion systems. Journal of Pharmaceutical Sciences, 60(9), 1281–1302. Chono, S., Takeda, E., Seki, T., & Morimoto, K. (2008). Enhancement of dissolution rate and gastrointestinal absorption of pranlukast by grinding with gelatin. International Journal of Pharmaceutics, 347, 71–78. Council of the Pharmaceutical Society of Great Britain. (2009). British Pharmacopoeia (Vol. I & II). London: Pharmaceutical Press. Crowley, K. J., & Zografi, G. (2002). Cryogenic grinding of indomethacin polymorphs and solvates: Assessment of amorphous phase formation and stability. Journal of Pharmaceutical Sciences, 91(2), 492–507. Dehghan, M. H. G., & Jafar, M. (2006). Improving dissolution of meloxicam using solid dispersions. Iranian Journal of Pharmaceutical Research, 4, 231–238. El-Maradny, H. A., Mortada, S. A., Kamel, O. A., & Hikal, A. H. (2008). Characterization of ternary complexes of meloxicam-HPβCD and PVP or L-arginine prepared by spray drying. Acta Pharmaceutica, 58, 455–466. Finholt, P. (1974). Influence of formulation on dissolution rate. In L. J. Leeson & J. T. Carstensen (Eds.), Dissolution Technology (pp. 106–146). Washington, DC: Academy of Pharmaceutical Sciences. Friedrich, H., Nada, A., & Bodmeier, R. (2005). Solid-state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers. Drug Development and Industrial Pharmacy, 31, 719–728. Galia, E., Horter, D., Reppas, C., & Dressman, J. B. (1998). Evaluation of dissolution media for predicting in vivo performance of class I and II drugs. Pharmaceutical Research, 15, 693–705. Garg, A., & Singh, S. (2009). Solid-state interaction of raloxifene HCl with hydrophilic carriers during co-grinding. Drug Development and Industrial Pharmacy, 35, 455–470. Ghorab, M. K., & Adeyeye, C. M. (2003). Enhanced bioavailability of ibuprofen co-granulated with β-cyclodextrin. Journal of Pharmaceutical Sciences, 92(8), 1691–1697. Grant, D. J. W. (1999). Theory and origin of polymorphism in pharmaceutical solids. New York: Marcel Dekker. Gurusamy, S., Kumar, V., & Mishra, D. N. (2006). Preparation and characterization of solid dispersions of meloxicam with PEG 6000. Chemical and Pharmaceutical Bulletin, 126(8), 657–666. Horter, D., & Dressman, J. B. (1997). Influence of physicochemical properties on drug dissolution in the GI tract. Advanced Drug Delivery Reviews, 25, 3–14. Krenn, M., Gamesik, M. P., Vogelsang, G. B., Colvin, O. M., & Leong, K. W. (1992). Improvement in solubility and stability of thalidomide with hydroxypropyl-β-cyclodextrin. Journal of Pharmaceutical Sciences, 81, 685–689. Pattewar, S. V. (2012). Solubility enhancement of simvastatin using HPMC E3 LV. International Journal of Pharmacy and Pharmaceutical Sciences, 4, 498–502. Racz, I. (1989). Drug formulation. New York: John Wiley & Sons. Reynolds, J. E. F. (Ed.). (2009). Martindale: The Complete Drug Reference (36th ed.). London: Pharmaceutical Press. Rowe, R. C., Sheskey, P. J., & Owen, S. C. (2006). Handbook of Pharmaceutical Excipients (6th ed.). London: Pharmaceutical Press. Serajuddin, A. T. M. (2007). Salt formation to improve drug solubility. Advanced Drug Delivery Reviews, 59, 603–616. Shargel, L., & Yu, A. B. C. (1999). Applied biopharmaceutics and pharmacokinetics (4th ed.). Appleton & Lange. Shargel, L., & Yu, A. B. C. (2005). Biofarmasetika dan farmakokinetika terapan (Edisi II, terj. Fasich & S. Sjamsiah). Surabaya: Airlangga University Press. Shakhtshneider, T. P., Vasilchenko, M. A., & Politov, A. A. (1996). Mechanochemical preparation of solid dispersions of ibuprofen with polyethylene glycol. International Journal of Pharmaceutics, 130, 25–32. Sugimoto, M., Okayaki, T., Narisawa, S., Koida, Y., & Nakajima. (1998). Improvement of dissolution and bioavailability of poorly water-soluble drugs by novel co-grinding method. International Journal of Pharmaceutics, 160, 11–19. Turck, D., Roth, W., & Busch, U. (1996). Clinical pharmacokinetics of meloxicam. British Journal of Rheumatology, 35, 13–16. United States Pharmacopeial Convention. (2002). United States Pharmacopeia 25 & National Formulary 20. Rockville: USP Convention. US National Library of Medicine. (2007). DailyMed: Current medication information for meloxicam tablets. Bethesda: US National Library of Medicine. Vadher, A. H., Parikh, J. R., Parikh, R. H., & Solanki, A. B. (2009). Preparation and characterization of co-ground mixture of aceclofenac and Neusilin US2 for dissolution enhancement. AAPS PharmSciTech, 10, 606–614. Vippagunta, S. R., Brittain, H. G., & Grant, D. J. W. (2001). Crystalline solids. Advanced Drug Delivery Reviews, 48, 3–26. Wade, A., & Paul, J. W. (1994). Handbook of Pharmaceutical Excipients (2nd ed.). London: Pharmaceutical Press. Zhang, G. Z., Law, D., Schmitt, E. A., & Qiu, Y. (2004). Phase transformation considerations in solid oral dosage forms. Advanced Drug Delivery Reviews, 56, 371–390.
local.eprints.dirdisk0/00/52/09/79
local.eprints.divisionS1F2024
local.eprints.id520979
local.eprints.typethesis/2Sarjana
local.eprints.urihttp://scholar.unand.ac.id/520979/
local.fakultasFakultas Farmasi
local.identifier.nim0811012034
local.prodiS1 Farmasi
local.thesis.levelSkripsi

Files

Collections